Anaerobic bacterial and protozoal deoxyribonucleic acid (DNA) (DNA)

Anaerobic bacterial and protozoal deoxyribonucleic acid (DNA) is the fundamental genetic material for microorganisms that exist in anaerobic or microaerophilic environments. It is the primary target for nitroimidazole antibiotics, which are prodrugs that require metabolic activation within the pathogen (StatPearls, 2023). In these organisms, low-redox-potential electron transport proteins, such as ferredoxin or flavodoxin, reduce the nitro group of the drug to form short-lived, highly reactive nitro-radical intermediates (PubMed, PMC1074380). These radicals interact directly with the DNA molecule, causing covalent binding, strand breakage, and loss of the helical structure. This damage effectively inhibits DNA synthesis and leads to rapid cell death (PubChem, CID 4173). This mechanism provides high selectivity for anaerobic pathogens because aerobic cells lack the necessary low-redox-potential electron transport systems to activate the drug. Consequently, this target is critical in the treatment of infections caused by anaerobic bacteria like Bacteroides and Clostridium, as well as protozoa like Trichomonas and Giardia (NIH, 2022).

Other names

Microbial DNABacterial DNAProtozoal DNAAnaerobic DNA

Nitroimidazole drugs undergo reductive activation by microbial electron transport proteins like ferredoxin in anaerobic conditions, forming reactive radical intermediates that cause DNA strand breakage and destabilization of the DNA helix (StatPearls, 2023).